Jeff Geschwind, MD serves as Medical Director for Oncology at NAMSA. In this role, he guides critical clinical research for image-guided therapies, helping bring innovative cancer treatments from the lab to patients. https://www.academia.edu/143398007/Targeting_Tumor_Glycolysis_A_Promising_Frontier_in_Cancer_Therapy